Gareth E, Lim L, Patricia L Brubaker
Medicines in the GLP-1 RA class currently marketed in Australia are: Ozempic (semaglutide) Wegovy (semaglutide) Saxenda (liraglutide) Trulicity (dulaglutide) Mounjaro (tirzepatide) According to the TGA, regulators received dozens of reports of suicidal ideation , as well as suicide attempts and significant mood disturbances, among people taking these medications
These data were first presented by Nakul Ganju, MD, of Howard University Hospital, Washington, DC, at the 2026 Crohns and Colitis Congress on Friday, January 23, 2026, in Las Vegas, Nevada
Our experienced team ensures you get the safest, most effective options tailored to your needs
So why is it so popular
Aunque Wegovy y Ozempic contienen el mismo principio activo (semaglutida), se diferencian en su dosificacin y en el resto de sus componentes